Cost-effectiveness of using environmental surveillance to target the roll-out typhoid conjugate vaccine

Vaccine. 2020 Feb 11;38(7):1661-1670. doi: 10.1016/j.vaccine.2019.12.061. Epub 2020 Jan 6.

Authors

Brittany L Hagedorn¹, Jillian Gauld², Nicholas Feasey³, Hao Hu²

Affiliations

¹ Institute for Disease Modeling, 3150 139th Ave SE, Bellevue, WA 98005, USA. Electronic address: bhagedorn@idmod.org.
² Institute for Disease Modeling, 3150 139th Ave SE, Bellevue, WA 98005, USA.
³ Liverpool School of Tropical Medicine, Pembroke Place Liverpool, L3 5QA, UK.

PMID: 31917040
DOI: 10.1016/j.vaccine.2019.12.061

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Cost-Benefit Analysis*
Humans
Population Surveillance*
Typhoid Fever* / epidemiology
Typhoid Fever* / prevention & control
Typhoid-Paratyphoid Vaccines / administration & dosage
Typhoid-Paratyphoid Vaccines / economics*
Vaccines, Conjugate / administration & dosage
Vaccines, Conjugate / economics

Substances

Typhoid-Paratyphoid Vaccines
Vaccines, Conjugate